Andrei Coliţă

1.1k total citations
38 papers, 153 citations indexed

About

Andrei Coliţă is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Andrei Coliţă has authored 38 papers receiving a total of 153 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 16 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Andrei Coliţă's work include Acute Myeloid Leukemia Research (13 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). Andrei Coliţă is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). Andrei Coliţă collaborates with scholars based in Romania, France and Slovakia. Andrei Coliţă's co-authors include Daniel Coriu, Anca Coliţă, Alina Tănase, Youcef Chelghoum, Oana Stanca, C Charrin, D Fière, Ciprian Tomuleasa, Xavier Thomas and Horia Bumbea and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Oncology and PLoS neglected tropical diseases.

In The Last Decade

Andrei Coliţă

32 papers receiving 149 citations

Peers

Andrei Coliţă

HEMAT

GENET

PFM

PHEOH

Kento Umino Japan

Nicola Cantore Italy

Shinsuke Hirabayashi Japan

Jennifer Kaivers Germany

P Vivancos Spain

Haifaa Abdulhaq United States

Michelina Santopietro Italy

Bernardine Favre France

Valeria Cancelli Italy

Naïs Prade France

Kento Umino Japan

Andrei Coliţă

65 ×0.7

HEMAT

32 ×0.6

GENET

35 ×1.1

41 ×1.4

PFM

15 ×0.6

PHEOH

Citations per year, relative to Andrei Coliţă Andrei Coliţă (= 1×) peers Kento Umino

Countries citing papers authored by Andrei Coliţă

Since Specialization

Citations

This map shows the geographic impact of Andrei Coliţă's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrei Coliţă with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrei Coliţă more than expected).

Fields of papers citing papers by Andrei Coliţă

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrei Coliţă. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrei Coliţă. The network helps show where Andrei Coliţă may publish in the future.

Co-authorship network of co-authors of Andrei Coliţă

This figure shows the co-authorship network connecting the top 25 collaborators of Andrei Coliţă. A scholar is included among the top collaborators of Andrei Coliţă based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrei Coliţă. Andrei Coliţă is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stanca, Oana, et al.. (2025). Navigating the New Era in Myelodysplastic Neoplasms: A Review of Prognostic Implications of the IPSS-M Score and 2022 WHO Classification. Hematology Reports. 17(6). 58–58.

Coliţă, Andrei, et al.. (2025). Insights into Pediatric GATA2-Related MDS: Unveiling Challenges in Clinical Practice. Biomedicines. 13(4). 827–827.

Coliţă, Andrei, et al.. (2024). Postoperative Thrombocytopenia after Revision Arthroplasty: Features, Diagnostic and Therapeutic Considerations. Life. 14(9). 1124–1124.

Coliţă, Andrei, et al.. (2023). A Review of FLT3 Kinase Inhibitors in AML. Journal of Clinical Medicine. 12(20). 6429–6429. 27 indexed citations

Coliţă, Andrei, Alina Tănase, Ciprian Tomuleasa, & Anca Coliţă. (2023). Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia in the Era of All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO). Cancers. 15(16). 4111–4111. 3 indexed citations

Căruntu, Constantin, Sergiu Paşca, Cristian Scheau, et al.. (2023). The Significance of CD20 Intensity Variance in Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia. Journal of Clinical Medicine. 12(4). 1451–1451. 1 indexed citations

Papuc, Sorina Mihaela, Viola Maria Popov, Maria Dobre, et al.. (2021). Delineation of Molecular Lesions in Acute Myeloid Leukemia Patients at Diagnosis: Integrated Next Generation Sequencing and Cytogenomic Studies. Genes. 12(6). 846–846. 4 indexed citations

Paşca, Sergiu, Andrei Roman, Bobe Petrushev, et al.. (2021). Ibrutinib Monotherapy as Bridge-to-Transplant for Relapsed/Refractory Primary Oculo-Cerebral Lymphoma. Journal of Clinical Medicine. 10(19). 4483–4483. 2 indexed citations

Coliţă, Andrei, et al.. (2021). Comparison of peripheral blood stem cell mobilization with filgrastim versus pegfilgrastim in lymphoma patients - single center experience.. Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(3). 1080–1087.

10.

Coliţă, Andrei, Daniel Coriu, Alina Tănase, et al.. (2020). Single-Center Experience With Epigenetic Treatment for Juvenile Myelomonocytic Leukemia. Frontiers in Oncology. 10. 484–484. 3 indexed citations

11.

Tănase, Alina, Andrei Coliţă, Laura Mihaela Ștefan, et al.. (2020). Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma—Romanian Experience. Journal of Clinical Medicine. 9(8). 2417–2417. 14 indexed citations

12.

Coliţă, Andrei, Anca Coliţă, Horia Bumbea, et al.. (2019). LEAM vs. BEAM vs. CLV Conditioning Regimen for Autologous Stem Cell Transplantation in Malignant Lymphomas. Retrospective Comparison of Toxicity and Efficacy on 222 Patients in the First 100 Days After Transplant, On Behalf of the Romanian Society for Bone Marrow Transplantation. Frontiers in Oncology. 9. 892–892. 15 indexed citations

13.

Stănculeanu, Dana Lucia, et al.. (2018). APPLY: A prospective observational study of clinical practice patterns of darbepoetin alfa use in patients with chemotherapy-induced anemia in Romania. memo - Magazine of European Medical Oncology. 11(2). 144–151. 2 indexed citations

14.

Coriu, Daniel, et al.. (2016). The impact of additional cytogenetic abnormalities at diagnosis and during therapy with tyrosine kinase inhibitors in Chronic Myeloid Leukaemia.. PubMed. 8(4). 502–8. 13 indexed citations

15.

Dobrea, Camelia, et al.. (2015). A trans-theoretical approach to alcohol abuse profile in the general population of an islamic country - Mashhad, Iran.. PubMed. 8(1). 55–61. 5 indexed citations

16.

Coliţă, Andrei, et al.. (2013). Fludarabine, Low-Dose Cyclophosphamide and Rabbit Antithymocyte Globulin Allowed Stable Engraftment After Allogeneic Peripheral Blood Stem Cell Transplantation for Poly-Transfused Dyskeratosis Congenita Patient: Case Report. Transplantation Proceedings. 45(7). 2849–2853. 4 indexed citations

17.

Coliţă, Andrei, et al.. (2012). Combined procedure of vascularized bone marrow transplantation and mesenchymal stem cells graft – An effective solution for rapid hematopoietic reconstitution and prevention of graft-versus-host disease. Medical Hypotheses. 79(3). 302–303. 2 indexed citations

18.

Coliţă, Andrei, et al.. (2012). Post-transplant lymphoproliferative disorders after solid organ transplantation in children.. PubMed. 107(4). 431–7. 1 indexed citations

19.

Coliţă, Andrei, et al.. (2001). Prognostic factors and treatment effects on survival in acute myeloid leukemia of M6 subtype: A retrospective study of 54 cases. Annals of Oncology. 12(4). 451–455. 18 indexed citations

20.

Coliţă, Andrei, et al.. (1988). [Acute promyelocytic leukemia. A study of 119 cases and a review of the literature].. PubMed. 40(1). 21–32. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact